Scholars Central

Conference abstractPublished 24 Nov 2016

Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoproteinspecific equine IgG

Authors: Andreas Suhrbier

QIMR Berghofer Medical Research Institute, Australia

Abstract

We describe production of purified equine IgG obtained from horses immunized with plasmid DNA followed by boosting with Kunjin replicon virus-like particles both encoding a modified Ebola glycoprotein. Administration of the equine IgG over 5 days to cynomolgus macaques infected 24 hours previously with a lethal dose of Ebola virus suppressed viral loads by more than 5 logs and protected animals from mortality. Animals generated their own Ebola glycoprotein-specific IgG responses 9-15 days after infection, with circulating virus undetectable by day 15-17. Such equine IgG may find utility as a post-exposure prophylactic for Ebola infection and provides a low cost, scalable alternative to monoclonal antibodies, with extensive human safety data and WHO-standardized international manufacturing capability available in both high and low income countries.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectVeterinary & Animal Science
  • BylineArticles whose byline prints “Andreas Suhrbier”